Live
- BJP rejects Kharge’s charge on EC’s ‘erosion’, says ‘most changes brought during Cong rule’
- 59 pc people seek GenAI smartphones by 2025 end globally: Report
- Crime Rate in Rachakonda Increases by 4% in 2024, Cybercrimes Surge by 42.5%
- AIM, Niti Aayog’s Youth Co:Lab challenge 2025 to foster innovation for disabled
- IIT Delhi students receive job offers from US, UK, UAE, Japan in abundance
- Pushpa 2 Leads to the Capture of Notorious Gangster Vishal Meshram in Nagpur
- WhatsApp to End Support for Older Android Phones From January 1, 2025
- CM Stalin Slams BJP-Led Government Over Election Rules Amendment
- Necrophilia: Chhattisgarh HC Observes Loophole In Indian Penal Code
- Jaipur tanker blast: Vasundhara Raje meets kin of injured, follows medical protocol
Granules India divests entire stake in its arm
Highlights
Granules India Ltd on Tuesday said it has divested its entire stake in Granules-Biocause Pharmaceutical Co Limited, a joint venture company located in China.
Hyderabad: Granules India Ltd on Tuesday said it has divested its entire stake in Granules-Biocause Pharmaceutical Co Limited, a joint venture company located in China.
Last year, Granules India had intimated about the divestment of the entire stake of the JV company for a total consideration of RMB 109 million (around Rs 110.8 crore).
"The transaction is completed and Granules-Biocause Pharmaceutical Co Limited ceased to be the joint venture company of Granules India Limited," Granules India said in a regulatory filing.
Next Story
ADVERTISEMENT
